greeksoup/ stock research

Merck (MRK) FY2023 results: revenue $60.1 billion, up 1.4% on the year

Merck & Co., Inc. (MRK) reported revenue of $60.1 billion for fiscal 2023, the year ended 31 December 2023, up 1.4% on the year before. Net income was $365 million, down 97.5%, and diluted earnings per share $0.14. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2024.

Revenue
$60.1 billion
+1.4% on the year
FY2016FY2023
Operating margin
n/a
FY2016FY2023
Net income
$365 million
-97.5% on the year
FY2016FY2023
Diluted EPS
$0.14
-97.5% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue60,11559,28348,704+1.4%
Cost of revenue16,12617,41113,626-7.4%
Gross profit43,98941,87235,078+5.1%
Gross margin73.2%70.6%72.0%
Research and development30,53113,54812,245+125.4%
Selling, general and administrative10,50410,0429,634+4.6%
Interest expense1,146962806+19.1%
Pre-tax income1,88916,44413,879-88.5%
Income tax1,5121,9181,521-21.2%
Effective tax rate80.0%11.7%11.0%
Net income36514,51913,049-97.5%
Net margin0.6%24.5%26.8%
Diluted EPS$0.14$5.71$5.14-97.5%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow13,00619,09514,109-31.9%
Capital expenditure3,8634,3884,448-12.0%
Free cash flow9,14314,7079,661-37.8%
Free cash flow margin15.2%24.8%19.8%
Cash from investing-14,083-4,960n/a
Cash from financing-4,810-9,119n/a
Depreciation and amortisation3,8283,9243,178-2.4%
Share-based compensation645541479+19.2%
Buybacks1,3460.0840
Dividends paid7,4457,0126,610+6.2%
Dividend per share$2.96$2.80$2.64+5.7%
Diluted shares, weighted2,547m2,542m2,538m+0.2%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity37,58145,99138,184-18.3%
Non-controlling interest54.067.073.0-19.4%
Debt35,10030,70033,100+14.3%
Operating lease liabilities9281,0131,225-8.4%
Other liabilities33,01231,38933,112+5.2%
Total liabilities and equity106,675109,160105,694-2.3%
Fixed assets23,05121,42219,279+7.6%
Goodwill21,19721,20421,264-0.0%
Intangible assets18,01120,26922,933-11.1%
Investments5041,513370-66.7%
Cash and equivalents6,84112,6948,096-46.1%
Receivables10,3499,4509,230+9.5%
Inventory6,3585,9115,953+7.6%
Other assets20,36416,69718,569+22.0%
Total assets106,675109,160105,694-2.3%

10-K for the year ended 31 December 2023, filed 26 February 2024: the filing.